This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Pharmacology
AML with FLT-3 mutation is treated by : 
Select and explain. 
A. Crizotinib, B. Gilteritinib, C. Acalabrutinib, D. Ibrutinib
B: Gilteritinib
Answer: B: Gilteritinib 
Explanation: Gilteritinib inhibits FMS like tyrosine Kinase 3 (FLT-3) and hence used in the treatment of AML with FLT-3 mutation.